Microtentacle Imaging for Metastatic Risk Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments often overlook the effects on circulating tumor cells (CTCs), leading to increased metastatic risk due to the focus on attached tumor cells, and existing imaging technologies struggle to detect early metastasis, making it difficult to predict patient outcomes and guide therapy effectively.
Innovation Solution
Developing methods to detect and image microtentacles on primary tumor cells, which involve isolating living, non-adherent tumor cells, and using high-speed confocal microscopy to assess microtentacle formation and drug responses, allowing for personalized treatment approaches.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current cancer treatments focus on attached tumor cells, then treatment effectiveness on primary tumors is improved, but circulating tumor cells are overlooked leading to increased metastatic risk
Solution Approach 1:
The invention segments the tumor cell population into two distinct categories: attached tumor cells and circulating tumor cells (CTCs). By developing separate detection and treatment approaches for each segment, the method ensures that both cell types are addressed. Specifically, the patent uses microfluidic devices to isolate and analyze CTCs from blood samples, enabling targeted therapeutic interventions that do not compromise the effectiveness of primary tumor treatment while simultaneously addressing metastatic risk.
Solution Approach 2:
The invention introduces microfluidic devices as an intermediary tool that bridges the gap between detecting attached tumor cells and monitoring CTCs. These devices serve as a mediator by capturing, isolating, and characterizing CTCs from complex blood samples, providing critical information about metastatic potential without interfering with standard primary tumor treatments. This intermediary approach enables dual-focused therapy.
2Measurement precision
If existing imaging technologies are used, then standard tumor detection is achieved, but early metastasis detection is insufficient making it difficult to predict patient outcomes
Solution Approach 1:
The invention performs preliminary detection and characterization of CTCs before metastatic lesions become clinically apparent. By analyzing CTCs in blood samples using microfluidic devices and imaging techniques, the method identifies metastatic risk early in the disease process. This preliminary action provides prognostic information that complements standard tumor detection, enabling earlier intervention and more accurate outcome prediction.
Solution Approach 2:
The invention adds a new dimension to tumor detection by moving from solely imaging primary tumors to also analyzing circulating cells in the bloodstream. This dimensional expansion from tissue-based detection to fluid-based detection enables comprehensive monitoring of both primary tumor status and metastatic potential, providing a more complete picture of disease progression and patient prognosis.
3Measurement precision
If high-speed confocal microscopy is used to image microtentacles, then detection precision of metastatic markers is improved, but device complexity increases
Solution Approach 1:
The invention segments the imaging task into two distinct stages: first, microfluidic devices capture and isolate individual CTCs, presenting them one at a time; second, high-speed confocal microscopy images the isolated cells. This segmentation allows the complex imaging task to be divided into manageable steps, where the microfluidic preparation simplifies the subsequent imaging requirements and reduces overall system complexity.
Solution Approach 2:
The invention introduces microfluidic isolation devices as an intermediary between the blood sample and the confocal microscope. This intermediary system performs preliminary cell isolation, enrichment, and positioning, which simplifies the imaging task and reduces the complexity burden on the microscope system. The microfluidic device acts as a buffer that handles the complex sample preparation, allowing the microscope to focus solely on high-resolution imaging.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the identification of patients at risk for metastasis and provides a rapid method to assess how cancer drugs affect CTCs, potentially reducing long-term metastatic risk by tailoring treatments to inhibit microtentacle formation.
Implementation Method 1
image the one or more living, non-adherent primary tumor cells and detect the microtentacles
Data Source
AI summary
The present invention provides a method for imaging microtentacles on isolated, living, non-adherent primary tumor cells from a cancer subject comprising: i) obtaining one or more living, non-adherent primary tumor cells that has been isolated from a solid tumor from the subject; and ii) imaging the one or more living, non-adherent primary tumor cells and detecting the microtentacles.